PACED Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Preserving Access to Cost Effective Drugs Act or the PACED Act
This bill prohibits patent owners from asserting tribal sovereign immunity as a defense in certain proceedings before the U.S. Patent and Trademark Office, including patent validity challenge proceedings before the Patent Trial and Appeal Board (PTAB). The prohibition also applies to court actions and proceedings before the International Trade Commission.
Sovereign immunity for foreign states shall apply in the PTAB as it applies in federal court. The abrogation of sovereign immunity shall not apply to states or institutions of higher education (i.e., public state universities and institutions).
Placed on Senate Legislative Calendar under General Orders. Calendar No. 129.
- Introduced in Senate Formatted Text PDF Formatted XML
- Reported to Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 440: PACED Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-440/
"S. 440: PACED Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-440/.
S. 440, 116th Cong. (2026), https://openamerica.io/bill/116-S-440/.
[S. 440: PACED Act](https://openamerica.io/bill/116-S-440/)